An unusual multiplex systemic lupus erythematosus family with high prevalence of nephropathy, late-onset disease, and one member with disease-onset post-hiv therapy

Journal of Clinical Rheumatology

Volumn 14, Issue 1, 2008, Pages 34-37

  Jakez Ocampo, Juan ^a   Carrillo Maravilla, Eduardo ^a   Richaud Patin, Yvonne ^a   Soto Vega, Elena ^a   Atisha Fregoso, Yemil ^a   Llorente, Luis ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Acquired immunodeficiency syndrome; Multiplex SLE family; Systemic lupus erythematosus

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; NAPROXEN; PREDNISONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTHRALGIA; ARTICLE; ARTICULAR CARTILAGE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG WITHDRAWAL; ECCHYMOSIS; EDEMA; ENVIRONMENTAL FACTOR; EPISTAXIS; ESOPHAGUS CANDIDIASIS; FACE ERYTHEMA; FAMILY; FEMALE; GENETIC LOAD; HEART INFARCTION; HEREDITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOVENTILATION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; MALE; MONONEUROPATHY; PHOTOSENSITIVITY; PLEURA EFFUSION; PNEUMOCYSTIS CARINII; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PSORIASIS; SEPTICEMIA; SKIN; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; ADOLESCENT; CASE REPORT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; ONSET AGE; PEDIGREE;

ADOLESCENT; ADULT; AGE OF ONSET; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEDIGREE;

EID: 44449169363     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181639abe     Document Type: Article

References (22)

1. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56:481-490.
2. Block SR, Winfield JB, Lockshin MD, et al. Studies of twins with systemic lupus. A review of the literature and presentation of 12 additional sets. Am J Med. 1975;59:533-552.
3. Jarvinen P, Kaprio J, Makitalo R, et al. Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: An increased prevalence of disease in MZ twins and concordance of disease features. J Intern Med. 1992;231:67-72.
4. Deapen D, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992; 35:311-318.
5. Koskenmies S, Widen E, Kere J, et al. Familial systemic lupus erythematosus in Finland. J Rheumatol. 2001;28:758-760.
6. Michel M, Johanet C, Meyer O, et al. Familial lupus erythematosus. Clinical and immunologyc features of 125 multiplex families. Medicine (Baltimore). 2001;80:153-158.
7. Boddaert J, Huong du LT, Amoura Z, et al. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore). 2004;83:348-359.
8. Palacios R, Santos J, Valdivielso P, et al. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus. 2002;11:60-63.
9. Brunjes S, Zike K, Julian R. Familial systemic lupus erythematosus. A review of the literature with a report of ten additional cases in four families. Am J Med. 1961;30:529-536.
10. Sestak AL, Shaver TS, Moser KL, et al. Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree. J Rheumatol. 1999;26:1495-1499.
11. Anaya JM, Shoenfeld Y. Multiple autoimmune disease in a patient with hyperprolactinemia. IMAJ. 2005;7:740-741.
12. Walker SE, Allen SH, Hoffman RW, et al. Prolactin: a stimulator of disease activity in systemic lupus erythematosus. Lupus. 1995;4:3-9.
13. Rioux JD, Abbas AK. Paths to understand the genetic basis of autoimmune disease. Nature. 2005;435:584-589.
14. Leder AN, Flansbaum B, Zandman-Goddard G, et al. Antiphospholipid syndrome induced by HIV. Lupus. 2001;10:370-374.
15. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev. 2002;1:329-337.
16. Sekigawa I, Kaneko H, Hishikawa T, et al. HIV infection and SLE: their pathogenic relationship. Clin Exp Rheum. 1998;16:175-180.
17. Amadori A, Chieco-Bianchi L. B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol Today. 1990;11:374-379.
18. Meyaard L, Schuitemaker H, Miedema F. T-cell dysfunction in HIV infection :anergy due to defective antigen-presenting cell function? Immunol Today. 1993;14:161-164.
19. DeSimone J, Pomerantz RJ, Babinchak. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med. 2000;133:447-454.
20. Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome. Emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore). 2002;81:213-227.
21. Calabrese LH, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum. 2005;35:166-174.
22. Sherer Y, Gorstein A. , Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004;34:501-537.